1-3 of 3
Raouf Fetni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Ubiquitin Specific Peptidase 42 Gene ( USP42) Is Recurrently Involved as a Fusion Gene with RUNX1 in Acute Myeloid Leukemia with the t(7;21)(p22;q22) Cryptic Translocation.

Amelie Giguere, Sawcene Hazourli, Douja Meftah, Raouf Fetni, Pierre Chagnon, Josee Hebert
Journal: Blood
Blood (2006) 108 (11): 4273.
https://doi.org/10.1182/blood.V108.11.4273.4273
Published: 2006
Journal Articles

Incidence of Genomic Aberrations and Associated Efficacy from a Phase III Study Comparing Alemtuzumab (CAMPATH®, MABCAMPATH®) vs Chlorambucil as First Line Therapy for B-Cell Chronic Lymphocytic Leukemia (BCLL).

Tadeusz Robak, Anna Dmoszynska, Raouf Fetni, Ying Wang, Malika Belkacz, Cynthia Sirard, Mark Goldberg, Aleksander Skotnicki, Jiri Mayer, Peter Hillmen
Journal: Blood
Blood (2006) 108 (11): 2092.
https://doi.org/10.1182/blood.V108.11.2092.2092
Published: 2006
Journal Articles

Overexpression of MEL1 as a Novel Fusion Partner of AML1 in the Blastic Phase of Chronic Myeloid Leukemia with the Recurrent Cryptic Translocation t(1;21)(p36.3;q22).

Sawcene Hazourli, MS, Pierre Chagnon, PhD, Raouf Fetni, PhD, Lambert Busque, MD, Josee Hebert, MD
Journal: Blood
Blood (2005) 106 (11): 4332.
https://doi.org/10.1182/blood.V106.11.4332.4332
Published: 2005